Lyra Therapeutics Security Corporation

Call
Website
480 Arsenal St
Watertown, MA 02472
+1 (617) 393-4600
https://lyratherapeutics.com

Lyra Therapeutics is a clinical-stage biotechnology company based in Watertown, MA, focused on developing innovative therapies for the localized treatment of chronic rhinosinusitis (CRS). With a commitment to addressing the needs of the 14 million individuals in the United States suffering from this debilitating condition, Lyra aims to provide long-lasting treatment options that break the cycle of relentless medical management.

The company's lead product candidate, LYR210, features a bioabsorbable nasal mesh designed to deliver continuous anti-inflammatory medication directly to the sinonasal tissues for up to six months. By integrating advanced materials science with proven medication, Lyra Therapeutics is poised to transform the treatment landscape for CRS patients, offering a new solution for an often overlooked community.

Generated from the website

Also at this address

Own this business?
See a problem?

You might also like

Drugs and drug proprietaries

Acer Therapeutics Inc

Opexa Therapeutics is a biotechnology company that specializes in the development of patient-specific cellular therapies for the treatment of autoimmune diseases, such as multiple sclerosis and diabetes. It offers Tovaxin, which is a vaccine for early relapsing multiple sclerosis. The company also offers an adult stem cell program that enables the production of multipotent cells generated from patients white blood cells and provides means to differentiate these stem cells into other tissue types. Opexa Therapeutics offers solutions that minimize the threat of treatment rejection. It operates clinical advisory boards for multiple sclerosis and diabetes that take care of the supervision of related procedures. The company provides products to target individual s disease progression and modification.

Sage Therapeutics, Inc

Sage Therapeutics, Inc., based in Cambridge, MA, is focused on rethinking the delivery of care for patients and families affected by brain health disorders. Through innovative research programs and a commitment to patient advocacy, the company aims to transform the understanding and treatment of neurological conditions. In collaboration with partners like Shionogi Co. Ltd., Sage is advancing its clinical pipeline, including investigational treatments such as zuranolone. The company emphasizes safety and efficacy in its research, continually striving to improve outcomes for those impacted by brain health issues. Generated from the website
AVEO Oncology
Drugs and drug proprietaries

AVEO Oncology

AVEO Oncology is a Boston-based biopharmaceutical company dedicated to improving the lives of cancer patients through innovative medical solutions. As a subsidiary of LG Chem, the company focuses on developing and delivering effective treatments that address the unique challenges faced by individuals battling cancer. Committed to scientific advancement, AVEO's portfolio includes several promising therapies, such as FOTIVDA, Ficlatuzumab, and AV-380. The company's mission is driven by a passion for enhancing the quality of life for those affected by cancer, underscoring their focus on patient-centered care. Generated from the website
United States›Massachusetts›Watertown›Lyra Therapeutics Security Corporation

Partial Data by Infogroup (c) 2025. All rights reserved.